• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[血液透析患者的迟发性皮肤卟啉症]

[Porphyria cutanea tarda in hemodialyzed patients].

作者信息

Suga C, Ikezawa Z

机构信息

Department of Dermatology, Yokohama City University School of Medicine, Urafune Hospital.

出版信息

Nihon Rinsho. 1995 Jun;53(6):1484-90.

PMID:7616666
Abstract

Porphyria cutanea tarda (PCT) and similar vesiculobullous disorders have been described to develop frequently in patients with chronic renal failure during long-term hemodialysis. 9 cases of PCT in hemodialyzed patients and 1 case of PCT in continuous ambulatory peritoneal dialysis have been reported in Japan. Since these patients were often anuria, porphyrin analyzed in plasma, feces, and dialysate. Uroporphyrins, coproporphyrins and heptacarboxyric porphyrins in feces, and total porphyrins in plasma increased. The iron overload, aluminum hydroxide, plasticizers exuded from the tubing or other apparatus and some drug administered during dialysis are considered as triggering factors. Hemodialysis employed high-performance-membrane, hemodiafiltration, plasma exchange, were reported as successful treatment.

摘要

迟发性皮肤卟啉病(PCT)及类似的水疱大疱性疾病常在慢性肾衰竭患者长期血液透析过程中频繁出现。日本已报道9例血液透析患者患PCT,1例持续性非卧床腹膜透析患者患PCT。由于这些患者常无尿,故对血浆、粪便和透析液进行卟啉分析。粪便中的尿卟啉、粪卟啉和七羧基卟啉以及血浆中的总卟啉增加。铁过载、氢氧化铝、从管路或其他器械中渗出的增塑剂以及透析期间使用的某些药物被认为是触发因素。采用高性能膜血液透析、血液透析滤过、血浆置换被报道为成功的治疗方法。

相似文献

1
[Porphyria cutanea tarda in hemodialyzed patients].[血液透析患者的迟发性皮肤卟啉症]
Nihon Rinsho. 1995 Jun;53(6):1484-90.
2
Porphyria cutanea tarda in the setting of renal failure. Response to renal transplantation.肾衰竭背景下的迟发性皮肤卟啉病。对肾移植的反应。
Arch Dermatol. 1993 Mar;129(3):337-9.
3
[Chronic hemodialysis-related porphyria/pseudoporphyria].[慢性血液透析相关的卟啉病/假性卟啉病]
Orv Hetil. 1994 Sep 25;135(39):2131-6.
4
Bullous dermatosis of end-stage renal disease: a possible association between abnormal porphyrin metabolism and aluminium.
Nephrol Dial Transplant. 1996 Sep;11(9):1787-91.
5
[Porphyria cutanea tarda in a chronic hemodialysis patient].
Nihon Hifuka Gakkai Zasshi. 1989 Jun;99(7):819-26.
6
Porphyrin studies in chronic renal failure patients on maintenance hemodialysis.维持性血液透析慢性肾衰竭患者的卟啉研究
Photodermatol. 1987 Feb;4(1):14-22.
7
[Porphyria cutanea tarda, hemodialysis and HCV hepatopathy].迟发性皮肤卟啉症、血液透析与丙型肝炎病毒肝病
Nefrologia. 2002;22(6):570-3.
8
Management of porphyria cutanea tarda in the setting of chronic renal failure: a case report and review.慢性肾衰竭背景下迟发性皮肤卟啉病的管理:一例报告及文献复习
J Am Acad Dermatol. 2000 Apr;42(4):645-52.
9
Porphyria cutanea tarda in a chronic hemodialysis patient.一名慢性血液透析患者的迟发性皮肤卟啉症
Saudi J Kidney Dis Transpl. 2010 Sep;21(5):919-22.
10
Correlation between levels of free and protein-bound plasma porphyrin and urinary porphyrins in porphyria cutanea tarda.迟发性皮肤卟啉症中游离和蛋白结合血浆卟啉水平与尿卟啉之间的相关性。
Int J Biochem Cell Biol. 1995 Jun;27(6):585-8. doi: 10.1016/1357-2725(95)00017-J.

引用本文的文献

1
Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide.铝、氧化铝和氢氧化铝的人体健康风险评估。
J Toxicol Environ Health B Crit Rev. 2007;10 Suppl 1(Suppl 1):1-269. doi: 10.1080/10937400701597766.